-
1
-
-
77955069195
-
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
-
HAFFNER MC, ARYEE MJ, TOUBAJI A, ESOPI DM, ALBADINE R et al. Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat Genet 2010; 42: 668-675. http://dx.doi.org/10.1038/ng.613
-
(2010)
Nat Genet
, vol.42
, pp. 668-675
-
-
Haffner, M.C.1
Aryee, M.J.2
Toubaji, A.3
Esopi, D.M.4
Albadine, R.5
-
2
-
-
77955069822
-
On the origin of prostate fusion oncogenes
-
BARTEK J, HAMERLIK P, LUKAS J. On the origin of prostate fusion oncogenes. Nat Genet 2010; 42: 647-648. http://dx.doi.org/10.1038/ng0810-647
-
(2010)
Nat Genet
, vol.42
, pp. 647-648
-
-
Bartek, J.1
Hamerlik, P.2
Lukas, J.3
-
3
-
-
78649966606
-
Androgen-induced TMPRSS2: ERG fusion in nonmalignant prostate epithelial cells
-
BASTUS NC, BOYD LK, MAO X, STANKIEWICZ E, KUDAHETTI SC et al. Androgen-induced TMPRSS2: ERG fusion in nonmalignant prostate epithelial cells. Cancer Res 2010; 70: 9544-9548. http://dx.doi.org/10.1158/0008-5472.CAN-10-1638
-
(2010)
Cancer Res
, vol.70
, pp. 9544-9548
-
-
Bastus, N.C.1
Boyd, L.K.2
Mao, X.3
Stankiewicz, E.4
Kudahetti, S.C.5
-
4
-
-
82555172358
-
Androgen receptor-driven chromatin Looping in prostate cancer
-
WU D, ZHANG C, SHEN Y, NEPHEW K, WANG Q. Androgen receptor-driven chromatin Looping in prostate cancer. Trends Endocrinol Metab 2011; 22: 474-480. http://dx.doi.org/10.1016/j.tem.2011.07.006
-
(2011)
Trends Endocrinol Metab
, vol.22
, pp. 474-480
-
-
Wu, D.1
Zhang, C.2
Shen, Y.3
Nephew, K.4
Wang, Q.5
-
5
-
-
77952103123
-
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression
-
YU J, YU J, MANI RS, CAO Q, BRENNER CJ et al. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 2010; 17: 443-454. http://dx.doi.org/10.1016/j.ccr.2010.03.018
-
(2010)
Cancer Cell
, vol.17
, pp. 443-454
-
-
Yu, J.1
Yu, J.2
Mani, R.S.3
Cao, Q.4
Brenner, C.J.5
-
6
-
-
79951497419
-
The genomic complexity of primary human prostate cancer
-
BERGER MF, LAWRENCE MS, DEMICHELIS F, DRIER Y, CIBULSKIS K et al. The genomic complexity of primary human prostate cancer. Nature 2011; 470: 214-220. http://dx.doi.org/10.1038/nature09744
-
(2011)
Nature
, vol.470
, pp. 214-220
-
-
Berger, M.F.1
Lawrence, M.S.2
Demichelis, F.3
Drier, Y.4
Cibulskis, K.5
-
7
-
-
79951846237
-
Gene fusions find an ERG-way to tumor inflammation
-
MARTIN SK, KYPRIANOU N. Gene fusions find an ERG-way to tumor inflammation. Cancer Biol Ther 2011; 11: 418-420. http://dx.doi.org/10.4161/cbt.11.4.14499
-
(2011)
Cancer Biol Ther
, vol.11
, pp. 418-420
-
-
Martin, S.K.1
Kyprianou, N.2
-
8
-
-
79951838697
-
ERG oncogene modulates prostaglandin signaling in prostate cancer cells
-
MOHAMED AA, TAN SH, SUN C, SHAHEDUZZAMAN S, HU Y. et al. ERG oncogene modulates prostaglandin signaling in prostate cancer cells. Cancer Biol Ther 2011; 11: 410-417. http://dx.doi.org/10.4161/cbt.11.4.14180
-
(2011)
Cancer Biol Ther
, vol.11
, pp. 410-417
-
-
Mohamed, A.A.1
Tan, S.H.2
Sun, C.3
Shaheduzzaman, S.4
Hu, Y.5
-
9
-
-
79958096047
-
Prostate cancer: The revolution of the fusion genes
-
FERNANDEZ-SERRA A, RUBIO-BRIONES J, GARCIACASADO Z, SOLSONA E, LOPEZ-GUERRERO JA. Cancer de próstata: la revolucion de los genes de fusion. [Prostate cancer: the revolution of the fusion genes]. Actas Urol Esp 2011; 35: 420-428. http://dx.doi.org/10.1016/j.acuroe.2010.11.001
-
(2011)
Actas Urol Esp
, vol.35
, pp. 420-428
-
-
Fernandez-Serra, A.1
Rubio-Briones, J.2
Garciacasado, Z.3
Solsona, E.4
Lopez-Guerrero, J.A.5
-
11
-
-
80052841071
-
ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy
-
MINNER S, ENODIEN M, SIRMA H, LUEBKE AM, KROHN A et al. ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy. Clin Cancer Res 2011; 17: 5878-5888. http://dx.doi.org/10.1158/1078-0432.CCR-11-1251
-
(2011)
Clin Cancer Res
, vol.17
, pp. 5878-5888
-
-
Minner, S.1
Enodien, M.2
Sirma, H.3
Luebke, A.M.4
Krohn, A.5
-
12
-
-
33749029695
-
TMPRSS2: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
-
PERNER S, DEMICHELIS F, BEROUKHIM R, SCHMIDT FH, MOSQUERA JM et al. TMPRSS2: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res 2006; 66: 8337-8341. http://dx.doi.org/10.1158/0008-5472.CAN-06-1482
-
(2006)
Cancer Res
, vol.66
, pp. 8337-8341
-
-
Perner, S.1
Demichelis, F.2
Beroukhim, R.3
Schmidt, F.H.4
Mosquera, J.M.5
-
13
-
-
34248510706
-
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
-
DEMICHELIS F, FALL K, PERNER S, ANDREN O, SCHMIDT F et al. TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene 2007; 26: 4596-4599. http://dx.doi.org/10.1038/sj.onc.1210237
-
(2007)
Oncogene
, vol.26
, pp. 4596-4599
-
-
Demichelis, F.1
Fall, K.2
Perner, S.3
Andren, O.4
Schmidt, F.5
-
14
-
-
84862776695
-
ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortality
-
BISMAR TA, DOLPH M, TENG LH, LIU S, DONNELLY B. ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortality. Eur J Cancer 2012; 48: 538-46. http://dx.doi.org/10.1016/j.ejca.2012.01.001
-
(2012)
Eur J Cancer
, vol.48
, pp. 538-546
-
-
Bismar, T.A.1
Dolph, M.2
Teng, L.H.3
Liu, S.4
Donnelly, B.5
-
15
-
-
84861165073
-
Correlation of ERG expression and DNA methylation biomarkers with adverse clinicopathologic features of prostate cancer
-
KRON K, LJU L, TRUDEL D, KRON K, LJU L, TRUDEL D. Correlation of ERG expression and DNA methylation biomarkers with adverse clinicopathologic features of prostate cancer. Clin Cancer Res 2012; 18: 2896-2904. http://dx.doi.org/10.1158/1078-0432.CCR-11-2901
-
(2012)
Clin Cancer Res
, vol.18
, pp. 2896-2904
-
-
Kron, K.1
Lju, L.2
Trudel, D.3
Kron, K.4
Lju, L.5
Trudel, D.6
-
16
-
-
79959660044
-
Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas
-
CHAUX A, ALBADINE R, TOUBAJI A, HICKS J, MEEKER A et al. Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas. Am J Surg Pathol 2011; 35: 1014-1020. http://dx.doi.org/10.1097/PAS.0b013e31821e8761
-
(2011)
Am J Surg Pathol
, vol.35
, pp. 1014-1020
-
-
Chaux, A.1
Albadine, R.2
Toubaji, A.3
Hicks, J.4
Meeker, A.5
-
17
-
-
77954997528
-
Antibody-based detection of ERG rearrangement-positive prostate cancer
-
PARK K, TOMLINS SA, MUDALIAR KM, CHIU YL, ESGUEVA R et al. Antibody-based detection of ERG rearrangement-positive prostate cancer. Neoplasia 2010; 12: 590-598.
-
(2010)
Neoplasia
, vol.12
, pp. 590-598
-
-
Park, K.1
Tomlins, S.A.2
Mudaliar, K.M.3
Chiu, Y.L.4
Esgueva, R.5
-
18
-
-
79961031183
-
Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: Implications for pathological practice
-
VAN LEENDERS GJ, BOORMANS JL, VISSERS CJ, HOOGLAND AM, BRESSERS AA et al. Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice. Mod Pathol 2011; 24: 1128-1138. http://dx.doi.org/10.1038/modpathol.2011.65
-
(2011)
Mod Pathol
, vol.24
, pp. 1128-1138
-
-
Van Leenders, G.J.1
Boormans, J.L.2
Vissers, C.J.3
Hoogland, A.M.4
Bressers, A.A.5
|